Source - RNS
RNS Number : 8106R
Integumen PLC
05 March 2019

5 March 2019

Integumen plc

("Integumen" or "the Company")

Issue of Equity

Following the exercise of warrants at an exercise price of 0.65p per share (totalling £12,000), at a board meeting held on 4 March 2019 a total of 1,846,154 new ordinary shares of 0.01p each were allotted.

Application will be made for these shares to be admitting to trading on AIM, and Admission of the above shares is expected on or around 8 March 2019.

Total Voting Rights

For the purpose of the Disclosure Guidance and Transparency Rules, the Company's total issued ordinary share capital following Admission will be 456,673,026 ordinary shares of 0.01p each. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.


Integumen plc

Gerard Brandon, CEO


+44 (0) 7340 055 643

SPARK Advisory Partners Limited

(Nominated Adviser)


Neil Baldwin/Andrew Emmott

+44 (0) 113 370 8974

Hybridan LLP  (Broker)

Claire Noyce

+44 (0) 20 3764 2341



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit